tradingkey.logo
tradingkey.logo

Hims & Hers Health Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 4, 2025 9:02 PM
  • Hims & Hers Health Inc HIMS.N reported quarterly adjusted earnings of 17 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 6 cents. The mean expectation of twelve analysts for the quarter was for earnings of 15 cents per share. Wall Street expected results to range from 5 cents to 26 cents per share.

  • Revenue rose 72.6% to $544.83 million from a year ago; analysts expected $551.62 million.

  • Hims & Hers Health Inc's reported EPS for the quarter was 17 cents​.

  • The company reported quarterly net income of $42.51 million.

  • Hims & Hers Health Inc shares had risen by 25.5% this quarter and gained 158.7% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 2.6% in the last three months.​

  • In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 8 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for Hims & Hers Health Inc is $43.00, about 47.3% below its last closing price of $63.35

This summary was machine generated from LSEG data August 4 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

0.15

0.17

Beat

Mar. 31 2025

0.12

0.20

Beat

Dec. 31 2024

0.10

0.11

Beat

Sep. 30 2024

0.04

0.32

Beat

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI